Andrew Petroll, MS, MD

Professor

view physician profile

Locations

Froedtert Hospital
Infectious Disease Clinic - Froedtert Hospital
Inclusion Clinic, Sargeant Health Center
Inclusion Clinic, Specialty Clinics, Froedtert Hospital
Infectious Disease Clinic - Sargeant Health Center

Specialties

Infectious Disease

Languages

English

Education

MS
MD - Doctor of Medicine

Leadership Positions

Assistant Professor of Medicine
Assistant Professor of Psychiatry and Behavioral Medicine
Assistant Professor, Department of Population Health

Research Interests

Dr. Petroll is an infectious disease specialist with a focus on the care of HIV-positive patients. His research interests include how patients' risk behaviors for HIV transmission are addressed in clinical settings, how patient-physician interactions affect the disclosure and discussion of HIV risk behaviors, and how patient and physician characteristics influence such discussions. He is interested in studying the effectiveness of interventions aimed at improving HIV risk behavior discussions between health care providers and both HIV-negative and HIV-positive patients, assessing HIV testing behaviors within high-risk populations, and intervening to increase serostatus testing.

The Impact of a Breast Cancer Risk Assessment on the Decision for Gender-Affirming Chest Masculinization Surgery in Transgender and Gender-Diverse Individuals: A Pilot Single-Arm Educational Intervention Trial.

(Cortina CS, Purdy A, Brazauskas R, Stachowiak SM, Fodrocy J, Klement KA, Sasor SE, Krucoff KB, Robertson K, Buth J, Lakatos AEB, Petroll AE, Doren EL.) Ann Surg Oncol. 2024 Oct;31(11):7474-7482 PMID: 38940898 PMCID: PMC11452287 SCOPUS ID: 2-s2.0-85197404335 06/28/2024
ASO Visual Abstract: Tumors, Treatments, and Trust: Cancer Characteristics, Outcomes, and Screening Uptake in Transgender and Gender-Diverse Patients.

(Istl AC, Lawton S, Kamaraju S, Stolley M, Petroll AE, Cortina CS.) Ann Surg Oncol. 2024 Sep;31(9):5591-5592 PMID: 38864983 SCOPUS ID: 2-s2.0-85201029649 06/12/2024
Tumors, Treatments, and Trust: Cancer Characteristics, Outcomes, and Screening Uptake in Transgender and Gender-Diverse Patients.

(Istl AC, Lawton S, Kamaraju S, Stolley M, Petroll AE, Cortina CS.) Ann Surg Oncol. 2024 Sep;31(9):5560-5569 PMID: 38861206 PMCID: PMC11309885 SCOPUS ID: 2-s2.0-85195645715 06/11/2024
That's My Girl; I love her: The Promise of Compassionate, Inclusive Healthcare for Black Transgender Women to Support PrEP Use.

(Quinn KG, Randall L, Petroll AE, John SA, Wesp L, Amirkhanian Y, Kelly JA.) AIDS Behav. 2024 Sep;28(9):2899-2909 PMID: 38809388 SCOPUS ID: 2-s2.0-85194732550 05/29/2024
The Association Between Back Pain, Depression, and Quality of Life Among Older Adults Living with HIV in Rural Areas of the United States.

(Gliedt J, Walsh J, Quinn K, Petroll A.) Exp Aging Res. 2024 Jul 10:1-11 PMID: 38986005 SCOPUS ID: 2-s2.0-85198051700 07/10/2024
Acceptability, Feasibility, and Preliminary Impact of 4 Remotely-Delivered Interventions for Rural Older Adults Living with HIV.

(Walsh JL, Quinn KG, Hirshfield S, John SA, Algiers O, Al-Shalby K, Giuca AM, McCarthy C, Petroll AE.) AIDS Behav. 2024 Apr;28(4):1401-1414 PMID: 38170275 SCOPUS ID: 2-s2.0-85181232928 01/04/2024
Current Insurance Policy Coverage for Screening Mammography in Transgender and Gender-Diverse Individuals.

(Cortina CS, Siegel EL, Polovneff A, Sahyouni G, Neuner JM, Petroll AE, Stolley M.) Ann Surg Oncol. 2023 Nov;30(12):6978-6980 PMID: 37620531 PMCID: PMC10591886 SCOPUS ID: 2-s2.0-85168660167 08/25/2023
Home-based self-sampling vs clinician sampling for anal precancer screening: The Prevent Anal Cancer Self-Swab Study.

(Nyitray AG, Nitkowski J, McAuliffe TL, Brzezinski B, Swartz MD, Fernandez ME, Deshmukh AA, Ridolfi TJ, Lundeen SJ, Cockerham L, Wenten D, Petroll A, Hilgeman B, Smith JS, Chiao EY, Giuliano AR, Schick V, Prevent Anal Cancer Self-Swab Study Team.) Int J Cancer. 2023 Aug 15;153(4):843-853 PMID: 37158105 PMCID: PMC10330574 SCOPUS ID: 2-s2.0-85158976331 05/09/2023
Implementation determinants of HIV Self-Testing among young sexual minority men.

(Zapata JP, Petroll AE, Quinn KG, Zamantakis A, John SA.) Arch Public Health. 2023 Jun 21;81(1):113 PMID: 37344899 PMCID: PMC10283334 SCOPUS ID: 2-s2.0-85163192577 06/22/2023
Perceptions of Transgender and Nonbinary Persons Toward Breast and Cervical Cancer Development, Screening, and Potential Impact on Gender-Affirming Hormone Therapy.

(Roznovjak D, Petroll AE, Lakatos AEB, Narayan R, Cortina CS.) JCO Oncol Pract. 2023 May;19(5):e794-e800 PMID: 36800556 SCOPUS ID: 2-s2.0-85159542707 02/18/2023
Exploring preferences and decision-making about long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young sexual minority men 17-24 years old.

(John SA, Zapata JP, Dang M, Pleuhs B, O'Neil A, Hirshfield S, Walsh JL, Petroll AE, Quinn KG.) Sci Rep. 2023 Mar 29;13(1):5116 PMID: 36991027 PMCID: PMC10052280 SCOPUS ID: 2-s2.0-85151182091 03/30/2023
Uptake of Human Papillomavirus Vaccination by HIV Status and HIV Pre-exposure Prophylaxis (PrEP) Care Engagement Among Young Sexual Minority Men 17-24 Years Old in the USA.

(Pleuhs B, Walsh JL, Quinn KG, Petroll AE, Nyitray A, John SA.) Sex Res Social Policy. 2022 Dec;19(4):1944-1953 PMID: 36687804 PMCID: PMC9857745 01/24/2023

Andrew Petroll, MS, MD

Professor

Locations

Specialties

Languages

Inclusion Clinic

Infectious Disease Clinic

Sargeant Health Center

Education

Leadership Positions

Research Interests

Publications